Scholtz & Company’s ICU Medical ICUI Stock Holding History

Scholtz & Company’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-18,654	Closed	-$2.75M	–	45
2016 Q4	$2.75M	Buy	+18,654	New	+$2.7M	2.39%	21

Other funds holding ICUI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Scholtz & Company's ICUI Position: Q1 2017 in Review

Scholtz & Company sold out of ICU Medical (ICUI) in Q1 2017, closing a stake of 18,654 shares — an estimated $2.75M sold.

Scholtz & Company first reported a position in ICUI in Q4 2016 and held it in 1 quarter. The position peaked at $2.75M in Q4 2016. 230 funds tracked by Wall St. Rank hold ICUI as of Q1 2017.

Scholtz & Company reported no remaining ICU Medical position as of Q1 2017 after selling out during the quarter.
Scholtz & Company sold 18,654 ICU Medical shares in Q1 2017, an estimated $2.75M.
Scholtz & Company first reported a position in ICU Medical in Q4 2016 and held it in 1 quarter.
Scholtz & Company's ICU Medical position peaked at $2.75M in Q4 2016.
230 funds tracked by Wall St. Rank held ICU Medical as of Q1 2017.

Based on Scholtz & Company's 13F filing for Q1 2017, filed 12 May 2017.